よむ、つかう、まなぶ。

MC plus(エムシープラス)は、診療報酬・介護報酬改定関連のニュース、

資料、研修などをパッケージした総合メディアです。


04 参考資料1-123価肺炎球菌莢膜ポリサッカライドワクチン(肺炎球菌ワクチン)ファクトシート (27 ページ)

公開元URL https://www.mhlw.go.jp/stf/newpage_36630.html
出典情報 厚生科学審議会 予防接種・ワクチン分科会 予防接種基本方針部会 ワクチン評価に関する小委員会(第22回 12/1)《厚生労働省》
低解像度画像をダウンロード

資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。

Streptococcus pneumoniae serotype 3 pneumonia in extremely elderly people in a nursing
home unit in Kanagawa, Japan, 2013. Am J Geriatric Soc 62: 1197-1198,2014.
12.Fukuyama H, Yamashiro S, Kinjo K, Tamaki H, Kishaba T. Validation of sputum gram stain
for treatment of community-acquired pneumonia and haelthcare-associated pneumonia: a
prospective

observational

study.

BMC

Infect

Dis.

14:534,2014.

doi:

10.1186/1471-2334-14-534.
13.Smith MD, Derrington P, Evans R, Creek M, Morris R, Dance DA, et al.Rapid diagnosis of
bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus

pneumoniae urinary antigen test: a prospective, controlled clinical evaluation. J Clin
Microbiol. 41:2810-2813,2003
14.Pride MW, Huijts S, Wu K, Souza V, Passador S, Tinder C, et al. Validation of an
immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotype-specific
polysaccharides in human urine. Clin Vaccine Immunol. 19: 1131-1141, 2012.
15.Chang B, Nariai A, Sekizuka T, Akeda Y, Kuroda M, Oishi K, et al. Capsule switching and
antimicrobial resistance acquired during repeated Streptococcus pneumoniae pneumonia
episodes. J Clin Microbiol 2015; 53:3318–24.
16.Oishi T, Ishiwada N, Matsubara KN, Nishi J, Chang B, Tamura K, et al. Low opsonic activity
to the infecting serotype in pediatric patients with invasive pneumococcal disease.
Vaccine 31(5):845-9,2013
17.Yanagihara K, Watanabe A, Aoki N, Matsumoto T, Yoshida M, Sato J, et al. Nationwide
surveillance of bacterial respiratory pathogens conducted by the surveillance committee
of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases,
and the Japanese Society for Clinical Microbiology in 2012: General view of the pathogens’
antibacterial susceptibility. J Infect Chemother 23: 587-97,2017.
18.Suga S, Chang B, Asada K, Akeda H, Nishi J, Okada K, et al. Nationwide population-based
surveillance of invasive pneumococcal disease in Japanese children: Effects of the
seven-valent pneumococcal conjugate vaccine. Vaccine 33:6054-60,2015.
19.McGill F, Heyderman RS, Panagiotou S,Tunkel AR, Solomon T. Acute bacterial meningitis in
adults. Lancet. 388: 3036-47, 2016.
20.村上義孝、西脇祐司、金津真一、大場真梨、渡辺 彰.65 歳高齢者における 23 価肺炎球菌ポリ
26